The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series D | Alive

Total Raised


Last Raised

$38.87M | 1 yr ago

About Yikon Genomics

Yikon Genomics focuses on developing and providing genetic analytical products and services for in vitro diagnosis (IVD). The company also supplies single-cell amplification kits based on patented MALBAC technology that pre-amplify pico-grams level nucleic acids to microgram prior to genomic and epigenetic analysis, thereby resolving the common problems of insufficient quantity and heterogeneity of genetic materials from various sample sources.

Yikon Genomics Headquarter Location

Unit 301, Building A3, Bio-Nano Park, No.218 Xinghu Street, Suzhou Industrial Park Suzhou Industrial Park

Suzhou, Jiangsu, 215000,



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Yikon Genomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Yikon Genomics is included in 4 Expert Collections, including Medical Devices.


Medical Devices

7,913 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance



1,265 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data


Health IT

7,900 items

Yikon Genomics Patents

Yikon Genomics has filed 1 patent.

The 3 most popular patent topics include:

  • Genetics
  • Molecular biology
  • Rare diseases
patents chart

Application Date

Grant Date


Related Topics



Genetics, Syndromes, Rare diseases, Transcription factors, Molecular biology


Application Date


Grant Date


Related Topics

Genetics, Syndromes, Rare diseases, Transcription factors, Molecular biology



Latest Yikon Genomics News

Genetron Health, Yikon Genomics Team up for Reproductive Health Sequencing Assays

Aug 23, 2021

Save for later NEW YORK – Genetron Health said on Monday that it has entered into a strategic partnership with reproductive health firm Yikon Genomics. Financial and other terms of the deal between the two Chinese firms were not disclosed, but Genetron said it expects the partnership to contribute to its 2021 revenues. Under the agreement, Shanghai-based Yikon will have exclusive rights to use Genetron's benchtop S5 sequencing instrument for reproductive health applications in China. In addition, the companies will work together to develop and register new tests for the platform, Genetron said in a statement. Beijing-based Genetron will also support Yikon's commercialization efforts. Yikon currently provides pre-pregnancy, prenatal, and genetic disease testing for more than 400 hospital partners across China. The S5 next-generation sequencing platform, which was approved by China's National Medical Products Administration in 2019, is based on Thermo Fisher Scientific's Ion GeneStudio S5 sequencer and has previously been used in various oncology settings. In July, the company received CE marking for its eight-gene lung cancer sequencing test running on the S5 platform.

Yikon Genomics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Yikon Genomics Rank

  • When was Yikon Genomics founded?

    Yikon Genomics was founded in 2012.

  • Where is Yikon Genomics's headquarters?

    Yikon Genomics's headquarters is located at Unit 301, Building A3, Bio-Nano Park, No.218 Xinghu Street, Suzhou Industrial Park, Suzhou.

  • What is Yikon Genomics's latest funding round?

    Yikon Genomics's latest funding round is Series D.

  • How much did Yikon Genomics raise?

    Yikon Genomics raised a total of $95.76M.

  • Who are the investors of Yikon Genomics?

    Investors of Yikon Genomics include China Capital Investment Group, Qilin Fund, Oriza Holdings, Yunfeng Capital, Sinopharm Capital and 12 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.